Surgical training device
    22.
    发明授权

    公开(公告)号:US11830377B2

    公开(公告)日:2023-11-28

    申请号:US16765239

    申请日:2018-11-30

    CPC classification number: G09B23/28 A61B17/0401 A61B2017/00716

    Abstract: Disclosed is a suturing training device and a method of using the device. The device comprises a base having a first side and a second side, the base defining a plane. The device also comprises a first anchor and a second anchor positioned on the first side of the base. The first and second anchors are each connectable to a segment of tissue so that the tissue is suspended therebetween in use of the device. An actuator is associated with one or both of the first anchor and the second anchor. The actuator is actuatable to cause relative movement of the first and second anchors along the plane. A force gauge is configured to measure a force applied to the tissue when the first and second anchors are moved relative one another by the actuator.

    Immunogenic protein Pas n 1 from Bahia grass pollen

    公开(公告)号:US10293042B2

    公开(公告)日:2019-05-21

    申请号:US15705059

    申请日:2017-09-14

    Abstract: The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.

    Methods and compositions for modified ethanol inducible promoter systems
    27.
    发明授权
    Methods and compositions for modified ethanol inducible promoter systems 有权
    改良乙醇诱导型启动子系统的方法和组成

    公开(公告)号:US09434953B2

    公开(公告)日:2016-09-06

    申请号:US13978133

    申请日:2011-12-15

    CPC classification number: C12N15/8238 C12N15/113 C12N15/8241

    Abstract: The present invention provides nucleic acid molecules comprising one or more nucleotide sequences selected from the group consisting of the nucleotide sequence of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and/or SEQ ID NO:10 that can be operably linked to a promoter, thereby making the promoter inducible by a chemical compound that can induce the expression of the alcohol dehydrogenase system of Aspergillus nidulans. Methods for making an inducible promoter and for making the expression of a nucleotide sequence of interest inducible are also provided. Further provided are plants, plant parts, and plant cells, comprising the compositions of the present invention.

    Abstract translation: 本发明提供了包含一个或多个选自下组的核酸序列的核酸分子:SEQ ID NO:1,SEQ ID NO:3,SEQ ID NO:4,SEQ ID NO:5,SEQ ID NO: :6,SEQ ID NO:7,SEQ ID NO:8和/或SEQ ID NO:10,其可以可操作地连接到启动子,从而使启动子可诱导可诱导醇脱氢酶表达的化学化合物 构巢曲霉系统。 还提供了制备诱导型启动子和用于诱导感兴趣的核苷酸序列的表达的方法。 还提供植物,植物部分和植物细胞,其包含本发明的组合物。

    Fibronectin: growth factor chimeras
    29.
    发明授权
    Fibronectin: growth factor chimeras 有权
    纤连蛋白:生长因子嵌合体

    公开(公告)号:US09090706B2

    公开(公告)日:2015-07-28

    申请号:US13511776

    申请日:2010-11-30

    Abstract: Isolated protein complexes are provided comprising growth factors such as IGF-I, IGF-II, EGF, bFGF, or KGF and fibronectin, or at least domains thereof that enable binding to and activation of both a growth factor receptor, and an integrin receptor-binding domain of fibronectin. These protein complexes include synthetic proteins where the growth factor and fibronectin sequences are joined by a linker sequence. Also provided are uses of these protein complexes for stimulating or inducing cell migration and/or proliferation in wound healing, tissue engineering, cosmetic and therapeutic treatments such as skin replacement, skin replenishment and treatment of burns where epithelial cell migration is required. In other embodiments, the invention provides inhibition of cancer cell metastasis, particularly in relation to breast cancer.

    Abstract translation: 提供了分离的蛋白质复合物,其包含生长因子如IGF-I,IGF-II,EGF,bFGF或KGF和纤连蛋白,或至少其结构域,其能够结合生长因子受体和整联蛋白受体 - 纤连蛋白的结合结构域。 这些蛋白质复合物包括其中生长因子和纤连蛋白序列通过接头序列连接的合成蛋白质。 还提供了这些蛋白质复合物用于刺激或诱导伤口愈合,组织工程,化妆品和治疗性处理如皮肤置换,皮肤补充和治疗需要上皮细胞迁移的灼伤的细胞迁移和/或增殖的用途。 在其它实施方案中,本发明提供对癌细胞转移的抑制,特别是与乳腺癌相关。

    SLOWING MYOPIA PROGRESSION AND/OR THE TREATMENT OR PREVENTION OF MYOPIA OR A DISEASE OR CONDITION ASSOCIATED WITH MYOPIA
    30.
    发明申请
    SLOWING MYOPIA PROGRESSION AND/OR THE TREATMENT OR PREVENTION OF MYOPIA OR A DISEASE OR CONDITION ASSOCIATED WITH MYOPIA 审中-公开
    缓解MYOPIA进展和/或治疗或预防MYOPIA或与MYOPIA相关的疾病或病症

    公开(公告)号:US20150036102A1

    公开(公告)日:2015-02-05

    申请号:US14380058

    申请日:2013-02-21

    Abstract: The invention provides an ophthalmic lens comprising one or more oblique prismatic component, wherein the lens slows myopia progression and/or treats or prevents myopia or a disease or condition associated with myopia. The one or more oblique prismatic components may be base-down or base-down and base-in or base up and base-in. The one or more oblique prismatic components may be central and/or in a distance and/or near zone of the ophthalmic lens. The invention also provides an ophthalmic lens comprising a central base-down prism in a distance zone wherein the lens slows myopia progression and/or treats or prevents myopia or a disease or condition associated with myopia. Also provided is an optical device comprising one or more ophthalmic lenses and a method of slowing myopia progression and/or treating or preventing myopia or a disease or condition associated with myopia including using one or more ophthalmic lenses.

    Abstract translation: 本发明提供一种包括一个或多个倾斜棱镜部件的眼科镜片,其中镜片减慢近视进展和/或治疗或预防近视或与近视有关的疾病或病症。 一个或多个倾斜的棱柱部件可以是底部或底部的,并且基部或底部和底部。 一个或多个斜棱镜部件可以是眼镜片的中心和/或远离和/或近区域。 本发明还提供了一种眼镜片,其包括在距离区域中的中心底向下棱镜,其中镜片减缓近视进展和/或治疗或预防近视或与近视有关的疾病或病症。 还提供了包括一个或多个眼科镜片的光学装置和减轻近视进展和/或治疗或预防近视或与近视有关的疾病或病症的方法,包括使用一个或多个眼科镜片。

Patent Agency Ranking